Table 1

 Characteristics of definite, probable, and possible pyridoxine dependent patients

Patient*Birth yearDefiniteProbablePossibleGenderIntrauterine seizuresAge at 1st seizureAge at 1st pyridoxineInitial dose (mg)Age at trialMaintenance dose (mg/day)DevelopmentOther major diagnoses or complications
*Patient number of sibling in parentheses.
PPHN, persistent pulmonary hypertension of the newborn.
1 (5)1991XFNo2 days9 days150 50Delayed initially but currently normal
21992X?No4 days6 months1001.7 years100Delayed; attends special school
3 (7)1992XFNo<1 day2 months252 months60Normal
4 (6)1992X?No8 days2 months1002 months100Mildly affected motor skills
5 (1)1993XFNo2 days2 days50 50Psychomotor delay; attends special schoolPPHN, birth asphyxia
6 (4)1994XF???? 100Normal
7 (3)1995XMNo8 days8 days60 60Lost to follow up
81998XMNo<1 day3 days50 50DelayedHydrocephalus, cerebral palsy
92001X?No3 days8 months508 months50Psychomotor delay; poor language skills
102003XFYes<1 day2 days502 days50Psychomotor delay
112003XMNo1 day2 weeks? 100Normal